Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Inflammatory Bowel Diseases

Free Subscription 10.02.2020 2 Am J Gastroenterol 4 BMC Gastroenterol 2 Clin Gastroenterol Hepatol 1 Dig Dis Sci 1 Gastroenterol Hepatol 4 Inflamm Bowel Dis 1 J Clin Gastroenterol 6 J Crohns Colitis 2 PLoS One 1 Scand J Gastroenterol 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. KEDIA S, Mouli VP, Kamat N, Sankar J, et al
   Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis.
   Am J Gastroenterol. 2020 Feb 6. doi: 10.14309/ajg.0000000000000527.
   PubMed     Text format     Abstract available
   
   
2. HAMMAMI MB, Mahadevan U
   Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer.
   Am J Gastroenterol. 2020 Feb 4. doi: 10.14309/ajg.0000000000000515.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

3. ZHU XL, Xu XM, Chen S, Wang QM, et al
   Lupus enteritis masquerading as Crohn's disease.
   BMC Gastroenterol. 2019;19:154.
   PubMed     Text format     Abstract available
   
   
4. LI Y, Chen B, Gao X, Hu N, et al
   Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry.
   BMC Gastroenterol. 2019;19:145.
   PubMed     Text format     Abstract available
   
   
5. BAVARO DF, Ingravallo G, Signorile F, Fortarezza F, et al
   Splenic abscesses as a first manifestation of Crohn's disease: a case report.
   BMC Gastroenterol. 2019;19:144.
   PubMed     Text format     Abstract available
   
   
6. XIE C, Quan R, Hong F, Zou K, et al
   The culprit of mesalamine intolerance: case series and literature review.
   BMC Gastroenterol. 2019;19:138.
   PubMed     Text format     Abstract available
   
   

   
   Clin Gastroenterol Hepatol

7. MAGRO F, Estevinho MM
   Do Neutrophils Contribute to Development of Crohn's Disease and Ulcerative Colitis?"
   Clin Gastroenterol Hepatol. 2020 Jan 30. pii: S1542-3565(20)30111.
   PubMed     Text format    
   
   
8. LORES T, Goess C, Mikocka-Walus A, Collins KL, et al
   Integrated Psychological Care Reduces Healthcare Costs at a Hospital-Based Inflammatory Bowel Disease Service.
   Clin Gastroenterol Hepatol. 2020 Jan 30. pii: S1542-3565(20)30109.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

9. ZHU M, Xie J
   LncRNA MALAT1 Promotes Ulcerative Colitis by Upregulating lncRNA ANRIL.
   Dig Dis Sci. 2020 Feb 5. pii: 10.1007/s10620-020-06093.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterol Hepatol

10. PENA-VELEZ R, Almanza-Miranda E, Zaragoza-Arevalo GR
    Crohn's disease in a girl with VACTERL association: Can mitochondrial dysfunction coexist?
    Gastroenterol Hepatol. 2019;42:435-436.
    PubMed     Text format    
    
    

    
    Inflamm Bowel Dis

11. KORNBLUTH A
    Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?
    Inflamm Bowel Dis. 2020 Feb 7. pii: 5729887. doi: 10.1093.
    PubMed     Text format    
    
    
12. CARNEY H, Marrie RA, Bolton JM, Patten SB, et al
    Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 6. pii: 5728525. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
13. PENG Y, Thomas AS, Wei D, Tan D, et al
    An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia.
    Inflamm Bowel Dis. 2020 Feb 4. pii: 5721970. doi: 10.1093.
    PubMed     Text format    
    
    
14. JABANDZIEV P, Bohosova J, Pinkasova T, Kunovsky L, et al
    The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 3. pii: 5721205. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Gastroenterol

15. HELWIG U, Kostev K, Schmidt C
    Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany: Retrospective Analysis of a Large Prescription Database.
    J Clin Gastroenterol. 2020 Jan 31. doi: 10.1097/MCG.0000000000001323.
    PubMed     Text format     Abstract available
    
    

    
    J Crohns Colitis

16. QURAISHI MN, Acharjee A, Beggs AD, Horniblow R, et al
    A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways.
    J Crohns Colitis. 2020 Feb 4. pii: 5722016. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
17. YZET C, Brazier F, Fumery M
    Post-operative Entero-cutaneous Fistula Closure by Over-the-Scope Clip in Crohn's Disease.
    J Crohns Colitis. 2019;13:954-955.
    PubMed     Text format    
    
    
18. KOTWANI P, Terdiman J, Lewin S
    Tofacitinib for rescue therapy in acute severe ulcerative colitis: a real-world experience.
    J Crohns Colitis. 2020 Feb 5. pii: 5727212. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
19. OSTVIK AE, Svendsen TD, Granlund AVB, Doseth B, et al
    Intestinal epithelial cells express immunomodulatory ISG15 during active ulcerative colitis and Crohn's disease.
    J Crohns Colitis. 2020 Feb 5. pii: 5727513. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
20. LO B, Holm JP, Vester-Andersen MK, Bendtsen F, et al
    Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease - a Danish population-based inception cohort with 10 years of follow-up.
    J Crohns Colitis. 2020 Feb 4. pii: 5722012. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
21. AGRAWAL M, Kim ES, Colombel JF
    JAK inhibitors safety in ulcerative colitis: practical implications.
    J Crohns Colitis. 2020 Feb 1. pii: 5719575. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

22. ROBINSON SC, Chaudhary R, Jimenez-Saiz R, Rayner LGA, et al
    Kaiso-induced intestinal inflammation is preceded by diminished E-cadherin expression and intestinal integrity.
    PLoS One. 2019;14:e0217220.
    PubMed     Text format     Abstract available
    
    
23. KONDO K, Ohfuji S, Watanabe K, Yamagami H, et al
    The association between environmental factors and the development of Crohn's disease with focusing on passive smoking: A multicenter case-control study in Japan.
    PLoS One. 2019;14:e0216429.
    PubMed     Text format     Abstract available
    
    

    
    Scand J Gastroenterol

24. SIGURDSSON GV, Schmidt S, Mellstrom D, Ohlsson C, et al
    Altered body composition profiles in young adults with childhood-onset inflammatory bowel disease.
    Scand J Gastroenterol. 2020 Feb 1:1-9. doi: 10.1080/00365521.2020.1716061.
    PubMed     Text format     Abstract available
    
    

    
    Z Gastroenterol

25. KELLER R, Fusco S, Stange EF, Malek NP, et al
    Infodemiology of Crohn's disease and Ulcerative colitis using Google Trends - an approach to investigate patient needs.
    Z Gastroenterol. 2020 Feb 4. doi: 10.1055/a-1068-2877.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: